• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Re-evaluation of toxicity and long-term follow-up of isolated lung perfusion with melphalan in patients with resectable pulmonary metastases: a phase I and extension trial.

作者信息

Grootenboers Marco J J H, Schramel Franz M N H, van Boven Wim J, van Putte Bart P, Hendriks Jeroen M H, Van Schil Paul E Y

出版信息

Ann Thorac Surg. 2007 Mar;83(3):1235-6. doi: 10.1016/j.athoracsur.2006.09.061.

DOI:10.1016/j.athoracsur.2006.09.061
PMID:17307516
Abstract
摘要

相似文献

1
Re-evaluation of toxicity and long-term follow-up of isolated lung perfusion with melphalan in patients with resectable pulmonary metastases: a phase I and extension trial.美法仑隔离肺灌注治疗可切除肺转移瘤患者的毒性重新评估及长期随访：一项I期及扩展试验
Ann Thorac Surg. 2007 Mar;83(3):1235-6. doi: 10.1016/j.athoracsur.2006.09.061.
2
Isolated lung perfusion with melphalan for resectable lung metastases: a phase I clinical trial.美法仑隔离肺灌注治疗可切除性肺转移瘤：一项I期临床试验。
Ann Thorac Surg. 2004 Dec;78(6):1919-26; discussion 1926-7. doi: 10.1016/j.athoracsur.2004.05.058.
3
Long-term survival of a phase I clinical trial of isolated lung perfusion with melphalan for resectable lung metastases.Ⅰ期临床试验中用美法仑行孤立性肺灌注治疗可切除肺转移瘤的长期生存结果。
Eur J Cardiothorac Surg. 2010 Nov;38(5):621-7. doi: 10.1016/j.ejcts.2010.03.048. Epub 2010 May 15.
4
Pharmacokinetics of isolated lung perfusion with melphalan for resectable pulmonary metastases, a phase I and extension trial.美法仑用于可切除肺转移瘤的离体肺灌注的药代动力学，一项I期及扩展试验。
J Surg Oncol. 2007 Dec 1;96(7):583-9. doi: 10.1002/jso.20838.
5
Isolated lung perfusion with melphalan: pharmacokinetics and toxicity in a pig model.美法仑的离体肺灌注：猪模型中的药代动力学和毒性
J Surg Oncol. 2006 Apr 1;93(5):410-6. doi: 10.1002/jso.20498.
6
Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020.美法仑单独热灌注隔离肢体与美法仑加肿瘤坏死因子的随机多中心试验：美国外科医师学会肿瘤学组Z0020试验
J Clin Oncol. 2006 Sep 1;24(25):4196-201. doi: 10.1200/JCO.2005.05.5152.
7
Long-term functional morbidity after mild hyperthermic isolated limb perfusion with melphalan.
Eur J Surg Oncol. 1999 Oct;25(5):503-8. doi: 10.1053/ejso.1999.0686.
8
Isolated limb infusion for melanoma: a less morbid alternative to hyperthermic isolated limb perfusion in the US.
Expert Opin Drug Metab Toxicol. 2010 Sep;6(9):1033-7. doi: 10.1517/17425250903559881.
9
Phase II multicenter clinical trial of pulmonary metastasectomy and isolated lung perfusion with melphalan in patients with resectable lung metastases.肺转移瘤切除术和肺隔离灌注丝裂霉素治疗可切除肺转移瘤的 II 期多中心临床试验。
J Thorac Oncol. 2014 Oct;9(10):1547-53. doi: 10.1097/JTO.0000000000000279.
10
Hyperthermic isolated limb perfusion with tumor necrosis factor is a useful therapy for advanced melanoma of the limbs.肿瘤坏死因子介导的高温离体肢体灌注是治疗晚期肢体黑色素瘤的有效方法。
J Clin Oncol. 2007 Apr 10;25(11):1449-50; author reply 1450-1. doi: 10.1200/JCO.2006.09.8459.

引用本文的文献

1
Oligometastatic non-small cell lung cancer: is there a role for locoregional therapy?寡转移非小细胞肺癌：局部区域治疗有作用吗？
J Thorac Dis. 2017 Jul;9(7):1814-1817. doi: 10.21037/jtd.2017.06.108.